Disease Info Card

Tetralogy Of Fallot

Information about Tetralogy Of Fallot: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Tetralogy Of Fallot

Most recent studies have shown that Tetralogy Of Fallot shares some biological mechanisms with aortic-coarctation, aortic-valve-stenosis, atresia, atrial-septal-defects, cardiac-arrhythmia, congenital-atresia-of-pulmonary-valve, congenital-heart-defects, congenital-heart-disease, cyanosis, heart-diseases, heart-failure, heart-septal-defects, patent-ductus-arteriosus, pulmonary-stenosis, pulmonary-valve-insufficiency, pulmonary-valve-stenosis, regurgitation, stenosis, transposition-of-great-vessels, ventricular-septal-defects.

Among the many pathways, these few ones have gauged particular interests from scientists studying Tetralogy Of Fallot, and have been seen in publications frequently: Aging, Angiogenesis, Blood Circulation, Cell Migration, Coagulation, Dehiscence, Excretion, Fibrinolysis, Heart Development, Hemostasis, Inflammatory Response, Localization, Notch Signaling Pathway, Ossification, Oxygen Transport, Pathogenesis, Secretion, Translation, Transport, Transposition

Quite a number of genes have been found to play important roles in Tetralogy Of Fallot, such as AMY2A, BLOC1S6, CPB1, EPB42, F3, FEZF2, GATA4, GDF1, NKX2-5, PGR, PRH1, PVR, RANGAP1, SLC17A5, SS18L1, TBX1, TF, TMEM37. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.